Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abbott Laboratories
C C C C A C
C07D C07D C07D C07D A61P C07D
inventional inventional inventional inventional inventional inventional
Liangjun Nobuhiko Robert J. Tami J. Keith F. Rolf Clarence J. David A. Todd W. Jason P. John K. Wenping David A. Brian E. Darold L. Pamela L. Curt S. Dachun Michael D. Dale J. Allan C. Rong David J. David D. Hongmei Christopher E. Akhteruzzaman Sherie V L.
Lu Iwasaki Carrick Pilot-Matias McDaniel Wagner Maring Betebenner Rockway Shanley Pratt He DeGoey Green Madigan Donner Cooper Liu Tufano Kempf Krueger Zhang Grampovnik Anderson Mo Motter Molla Masse